HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Find → Understand → Decide

Stranded asset discovery

Find leads where development or the surrounding company stopped. Discovery priority is separate from buyer qualification.

Bounded historical coverage · 0 HIGH / 111 MEDIUM / 956 LOW. No current availability or investment recommendation is implied. SEC retrieval is partial.

1067 exact-label leads · page 12

LOW · POSSIBLE / INVESTIGATE

[177]Lu-DOTA-TATE

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

[68]Ga-HA-DOTATATE

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · UNKNOWN

[¹⁴C]Hydronidone

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · UNKNOWN confidence · New label

LOW · POSSIBLE / INVESTIGATE

AAT

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · UNKNOWN

Abrocitinib 200 mg

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · UNKNOWN confidence · New label

LOW · POSSIBLE / INVESTIGATE

Acamprosate

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · UNKNOWN

Actemra®

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · UNKNOWN confidence · New label

LOW · POSSIBLE / INVESTIGATE

Acthar Gel and Tacrolimus

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Activated Charcoal

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Active Cannabis

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · Prior label overlap

LOW · POSSIBLE / INVESTIGATE

Actos

Why stranded (event context): efficacy failure

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · Prior label overlap

LOW · POSSIBLE / INVESTIGATE

Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · Prior label overlap